Corebridge Financial’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Corebridge Financial’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-26,547	Closed	-$60.8K	–	3052
2024 Q2	$60.8K	Buy	+26,547	New	+$101K	﹤0.01%	2838

Corebridge Financial's GTHX Position: Q3 2024 in Review

Corebridge Financial sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 26,547 shares — an estimated $60.8K sold.

Corebridge Financial first reported a position in GTHX in Q2 2024 and held it in 1 quarter. The position peaked at $60.8K in Q2 2024. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

Corebridge Financial reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Corebridge Financial sold 26,547 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $60.8K.
Corebridge Financial first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
Corebridge Financial's G1 Therapeutics, Inc. Common Stock position peaked at $60.8K in Q2 2024.
0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Corebridge Financial's 13F filing for Q3 2024, filed 13 Nov 2024.